Site is loading…
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center is a clinical research site located in Reading, Pennsylvania, United States 19612-6052.
Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center has participated in 45 clinical trials with 1 currently active.
Therapeutic areas: Prostate Cancer, Fallopian Tube Cancer, Ovarian Cancer.
Sponsors: Radiation Therapy Oncology Group, Gynecologic Oncology Group, Eastern Cooperative Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Reading
Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center has 45 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer, Fallopian Tube Cancer, Ovarian Cancer.
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.